Signal transduction by the JNK group of MAP kinases

Cell

Volumn 103, Issue 2, 2000, Pages 239-252

  Davis, Roger J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

BIOSYNTHESIS; CELL DEATH; CELL DIFFERENTIATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL WALL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034644522     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)00116-1     Document Type: Review

References (132)

1. Distortion of proximodistal information causes JNK-dependent apoptosis in Drosophila wing
2. Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity
3. Regulation of JNK signaling by GSTβ
4. 2-terminal kinase
5. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor
6. Ras and Rho GTPases: A family reunion
7. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
8. Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation
9. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation
10. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation
11. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells
12. IB1, a JIP-1-related nuclear protein present in insulin-secreting cells
13. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells
14. Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling
15. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway
16. The c-Jun N-terminal kinase pathway and apoptotic signaling
17. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation
18. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation
19. 2-terminal kinase inhibits targeting of the protein phosphatase calcineurin to NFATc1
20. JNK1 is required for T cell-mediated immunity against Leischmania major infection
21. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway
22. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
23. Defective T cell differentiation in the absence of Jnk1
24. JNK is required for effector T-cell function but not for T-cell activation
25. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
26. An activity-dependent network of interactions links the Rel protein Dorsal with its cytoplasmic regulators
27. Control of MAPK signaling by Ste20- and Ste11-like kinases
28. Stress-induced Fas ligand expression in T cells is mediated through a MEK kinase 1-regulated response element in the Fas ligand promoter
29. JNK targets p53 ubiquitination and degradation in nonstressed cells
30. MEKK1/JNK signaling stabilizes and activates p53
31. Stress-activated kinases regulate protein stability
32. SEK1 deficiency reveals mitogen-activated protein kinase cascade crossregulation and leads to abnormal hepatogenesis
33. Inhibition of hypoxia/reoxygenation-induced apoptosis by an antisense oligonucleotide targeted to JNK1 in human kidney cells
34. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction
35. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction
36. BCL-2 family members and the mitochondria in apoptosis
37. Selective interaction of JNK protein kinase isoforms with transcription factors
38. Differential requirement for caspase 9 in apoptotic pathways in vivo
39. Execution of ASK1-induced apoptosis by the mitochondria-dependent caspase activation
40. Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia
41. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
42. c-Jun is essential for normal mouse development and hepatogenesis
43. 2-terminal kinase and caspase-3
44. Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development
45. Bcl-2 phosphorylation required for anti-apoptosis function
46. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway
47. Cellular transformation and malignancy induced by ras require c-jun
48. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation
49. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1
50. A Caenorhabditis elegans JNK signal transduction pathway regulates coordinated movement via type-D GABAergic motor neurons
51. ATF-2 has intrinsic histone acetyl-transferase activity which is modulated by phosphorylation
52. Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3
53. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
54. TAK1 mitogen-activated protein kinase kinase kinase is activated by auto-phosphorylation within its activation loop
55. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
56. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development
57. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
58. The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death
59. pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine
60. The stress-activated protein kinase subfamily of c-Jun kinases
61. Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro
62. Physical and functional interaction of filamin (actin-binding protein-280) and tumor necrosis factor receptor-associated factor 2
63. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
64. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis
65. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death
66. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin
67. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
68. Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-alpha activation of SAPK in melanoma cells
69. Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1
70. The mixed lineage kinase DLK utilizes MKK7 and not MKK4 as substrate
71. Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons
72. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1
73. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs
74. Planar polarity in the Drosophila eye: A multifaceted view of signaling specificity and cross-talk
75. Distinct domains of mouse dishevelled are responsible for the c-Jun N-terminal kinase/stress-activated protein kinase activation and the axis formation in vertebrates
76. cDNA cloning and mapping of a novel islet-brain/JNK-interacting protein
77. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3
78. Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4
79. ASK1 is essential for JNK/SAPK activation by TRAF2
80. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase
81. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector
82. Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain
83. Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner
84. Phosphorylation of c-jun mediated by MAP kinases
85. Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2
86. The Drosophila Jun-N-terminal kinase is required for cell morphogenesis but not for DJun-dependent cell fate specification in the eye
87. The JNK pathway regulates the in vivo deletion of immature CD4(+)CD8(+) thymocytes
88. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development
89. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2
90. MP1: A MEK binding partner that enhances enzymatic activation of the MAP kinase cascade
91. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
92. Cell signaling by receptor tyrosine kinases
93. Control of cell cycle progression by c-Jun is p53 dependent
94. Role of Gadd45 in apoptosis
95. Signal transduction by tumor necrosis factor mediated by JNK protein kinases
96. A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila
97. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73
98. The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and 2
99. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene
100. SEK1/MKK4 is required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development
101. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
102. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK
103. Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways
104. A conserved docking motif in MAP kinases common to substrates, activators and regulators
105. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor
106. 2-terminal kinase kinases
107. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
108. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1
109. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes
110. 2-terminal kinase in ventricular muscle cells
111. Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation
112. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals
113. A mammalian scaffold complex that selectively mediates MAP kinase activation
114. Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes
115. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
116. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension
117. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration
118. Crystal structure of JNK3: A kinase implicated in neuronal apoptosis
119. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway
120. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M
121. 2-terminal kinase activation, and defects in AP-1 transcriptional activity
122. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
123. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2
124. Mekk3 is essential for early embryonic cardiovascular development
125. The JIP group of mitogen-activated protein kinase scaffold proteins
126. Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice
127. FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis
128. Apaf1 is required for mitochondrial pathways of apoptosis and brain development
129. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17
130. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption
131. 2-terminal kinase regulation but does not cause a measurable defect in NF-kB activation
132. 2-terminal kinase/stress-activated protein kinase